TrialRadiation oncology (London, England)2019

Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002).

Jingwen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.